MOSCOW (MRC) -- In its meeting the Supervisory Board of Evonik Industries AG appointed Christian Kullmann (47) Deputy Chairman of the Executive Board with immediate effect, said the company in its press release.
Kullmann has been on the Executive Board since July 2014 and has the role of Chief Strategic Officer. He joined the company in 2003.
Werner Muller, Chairman of the Supervisory Board, says: "Christian Kullmann has rendered outstanding service to Evonik and gained great recognition both within and outside the company through the IPO preparations and the new corporate strategy. He will continue to support Evonik on its path of extraordinary success."
Klaus Engel, Chairman of the Executive Board, says: "I highly recommended Christian Kullmann as a Board Member at the time, and I now recommend him equally highly as my deputy. He stands for continuity and dependability towards employees, customers and investors. We will continue along our successful path in the same spirit of trusting cooperation."
As MRC informed earlier, Evonik did well in the first quarter in challenging business conditions. Overall, the Evonik Group’s sales contracted by 9 percent to EUR3,106 million (Q1 2015: EUR3,425 million). While demand for Evonik products was stable overall, selling prices declined by 7 percentage points.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world.
MRC